MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
"Triple Helix" Innovation Model
1. Triple Helix _ Sectors
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
Middle East & North Africa (MENA)
*Triple Helix Cluster & Developments Middle East
*Triple Helix Cluster & Developments: Israel
*Industry: Israel
Nucleix
Attachments
Using Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Bladder
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Lung
*Architects: Diagnostics_Liquid Biopsy
*Architects: Medical Device_Diagnostics_Epigenetics
*Industry: Israel
2016: 11 Early Stage Companies To Watch At BIO 2016
Children
2021: Liquid biopsy maker Nucleix rakes in $55M to develop blood tests to detect lung cancer early
2021: RA Capital Management led the round, with additional participation from new and existing investors including BlackRock-managed funds and accounts, Lilly Asia Ventures, OrbiMed and more.
EpiCheck uses next-generation sequencing to identify changes in DNA methylation that indicate the onset of cancer, then applies PCR techniques to translate those findings into scalable lab tests.
Founded 2008
Modi'in, Israel
The result is a simple blood or urine test that can detect cancer based on miniscule changes in a person’s DNA, allowing for much earlier diagnoses and less invasive methods than other tissue-based tests.